Michal Schwartz
- Developmental Neuroscience top 2%
- Neurology top 2%
- Neuroinflammation and Neurodegeneration Mechanisms 7
-
- Nerve injury and regeneration 11
- Ophthalmology top 2%
- Infectious Diseases top 5%
-
- Cytomegalovirus and herpesvirus research 13
- Herpesvirus Infections and Treatments 7
-
- Retinal Development and Disorders 12
- Genomics and Chromatin Dynamics 10
-
- Monoclonal and Polyclonal Antibodies Research 8
-
- Immune Response and Inflammation 5
- Co-authors
- Eti YolesNoam Stern‐GinossarMichael BelkinBatsheva KeremAharon NachshonEitan ZlotorynskiYael ShaniYaara Finkel
- Journals
- Nature (4 papers)Proceedings of the National Academy of Sciences (5 papers)Nucleic Acids Research (1 paper)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Michal Schwartz
92 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Developmental Neuroscience 270
- Neurology 441
- Cellular and Molecular Neuroscience 625
- Ophthalmology 241
- Infectious Diseases 458
Countries citing papers authored by Michal Schwartz
This map shows the geographic impact of Michal Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Schwartz more than expected).
Fields of papers citing papers by Michal Schwartz
This network shows the impact of papers produced by Michal Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Schwartz. The network helps show where Michal Schwartz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michal Schwartz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 16 | |
| 2 | 2022 | 31 | |
| 3 | 2022 | 43 | |
| 4 | SARS-CoV-2 uses a multipronged strategy to impede host protein synthesisbreakdown → | 2021 | 160 |
| 5 | The coding capacity of SARS-CoV-2breakdown → | 2020 | 382 |
| 6 | 2018 | 127 | |
| 7 | 2018 | 31 | |
| 8 | 2015 | 26 | |
| 9 | 2014 | 59 | |
| 10 | 2009 | 16 | |
| 11 | 2007 | 50 | |
| 12 | 2005 | 118 | |
| 13 | 2002 | 7 | |
| 14 | 1999 | 38 | |
| 15 | 1996 | 58 | |
| 16 | 1994 | 32 | |
| 17 | 1993 | 16 | |
| 18 | 1992 | 19 | |
| 19 | 1988 | 25 | |
| 20 | 1986 | 70 |
About Michal Schwartz
Michal Schwartz is a scholar working on Neurology, Developmental Neuroscience and Cellular and Molecular Neuroscience, having authored 92 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (13 papers), Retinal Development and Disorders (12 papers), Nerve injury and regeneration (11 papers), Genomics and Chromatin Dynamics (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Herpesvirus Infections and Treatments (7 papers) and Immune Response and Inflammation (5 papers). The work is most often cited by research in Developmental Neuroscience (270 citations), Neurology (441 citations) and Cellular and Molecular Neuroscience (625 citations). Michal Schwartz has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Eti Yoles, Noam Stern‐Ginossar, Michael Belkin, Batsheva Kerem, Aharon Nachshon, Eitan Zlotorynski, Yael Shani, Yaara Finkel, U. Otten and Philip Lazarovici. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.